Regulus Therapeutics Inc.

NASDAQ: RGLS · Real-Time Price · USD
8.11
0.16 (2.01%)
At close: Jun 05, 2025, 3:59 PM
8.13
0.31%
After-hours: Jun 05, 2025, 07:47 PM EDT

Regulus Therapeutics Revenue

Regulus Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Regulus Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
34
Market Cap
561.14M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.